Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Level ll Quote

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Jan 08, 2022 1:08pm

139 Views

Post# 34296287

RE:RE:RE:RE:RE:RE:RE:RE:RE:Level ll Quote

No apology needed and I didn't mean to sound critical, it's just that these manipulators don't need any help.

Oilminerdeluxe wrote: Steven, perhaps I should have been a bit more careful with my wording. My apologies. 2022 will be an interesting year no doubt. TLT could be a life changer for many of us.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide